Phoenix, AZ, United States of America

Kevin G Farl


Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 477(Granted Patents)


Company Filing History:


Years Active: 2001-2003

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kevin G. Farl in Vascular Prosthesis Technology

Introduction

Kevin G. Farl, an esteemed inventor based in Phoenix, AZ, United States, has made significant strides in the field of biomedical engineering. With a total of five patents to his name, Farl is recognized for his groundbreaking work in vascular prostheses, particularly using expanded polytetrafluoroethylene (ePTFE). His innovative methods have set new benchmarks in the manufacturing of vascular implants, contributing to advancements in medical technology.

Latest Patents

Farl's recent patents include methods for creating large diameter vascular prostheses and an expandable vascular prosthesis, both centered around the use of ePTFE. These methods involve a sophisticated process of extruding a PTFE tube and transforming it into an ePTFE tube. The innovative step of laterally dilating the tube in incremental stages, followed by calendering at elevated temperatures, allows for achieving a larger diameter with a reduced wall thickness compared to previous techniques. These vascular prostheses can be sintered with additional tubes to create laminated structures or can be integrated with wire stents, ensuring they maintain a cylindrical form.

Career Highlights

Throughout his career, Kevin G. Farl has demonstrated a commitment to pushing the boundaries of vascular technology. His role as an inventor at Endomed, Inc. allows him to spearhead projects that directly enhance patient care by improving the design and functionality of vascular implants. His dedication to innovation in this field is reflected in his patented methods, which aim to make surgical procedures safer and more effective for patients.

Collaborations

Farl has worked alongside notable colleagues, including William M. Colone and Barbara L. Teeter, at Endomed, Inc. These collaborations have been pivotal in refining the processes involved in developing new vascular technologies. Together, they strive to elevate the standards of vascular prostheses, leveraging their collective expertise to bring innovative solutions to the medical community.

Conclusion

Kevin G. Farl stands out as a significant figure in the invention of advanced vascular prostheses. His contributions through innovative methods have the potential to greatly impact patient outcomes in vascular surgeries. With a proven track record of patents and collaborative efforts, Farl continues to drive progress in the medical field, underscoring the importance of innovation in improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…